Involvement of TRPC6/NFAT axis and mitochondrial quality control in the protective effect of aerobic exercise against doxorubicin-induced cardiomyopathy
Doxorubicin (DOX), a common chemotherapeutic agent, leads to irreversible anthracycline-induced cardiomyopathy (AIC). Impaired mitochondrial quality control serves as a central pathogenic driver of AIC. Moreover, DOX provokes sustained overactivation of the TRPC6/NFAT cascade, generating self-amplifying excitation-transcription feedback in injured cardiomyocytes. Despite the well-documented cardioprotective potential of aerobic exercise, the causal interplay between TRPC6/NFAT signaling and mitochondrial homeostasis underlying this protection remains unclear. Male C57BL/6 J mice were randomly assigned to five groups with bidirectional pharmacological manipulation of TRPC6/NFAT activity: control, DOX, exercise + DOX, exercise + DOX + TRPC6 agonist hyperforin, and DOX + TRPC6 antagonist larixyl acetate. Aerobic exercise suppressed TRPC6/NFAT3 overactivation. This inhibition further normalized mitochondrial quality control by enhancing mitochondrial biogenesis, limiting excessive mitochondrial fission and suppressing excessive PINK1/Parkin-mediated mitophagy signaling. The improvement in mitochondrial homeostasis was accompanied by attenuated DOX-induced myocardial injury, hypertrophy, and interstitial fibrosis. Echocardiography revealed restored systolic function with elevated left ventricular ejection fraction (LVEF) and fractional shortening (LVFS). Treadmill testing further revealed recovered heart rate recovery (HRR), along with a longer exhaustive running distance and exercise duration. Notably, larixyl acetate recapitulated all exercise-conferred cardiac benefits, whereas hyperforin-mediated TRPC6/NFAT activation completely abrogated exercise-induced protection. In summary, aerobic exercise alleviates DOX-induced cardiomyopathy by disrupting the TRPC6/NFAT3 positive-feedback loop to restore mitochondrial quality control. This cascade of effects mitigates pathological myocardial remodeling, rescues left ventricular systolic performance, and increases systemic exercise tolerance, providing experimental evidence supporting exercise rehabilitation for patients with AIC.
Authors
- Long‐Xin Gui (ORCID: https://orcid.org/0000-0003-1517-2350)
- Hai-Xia Jiao
- Rui-Xing Wang
- Zhijuan Wu (ORCID: https://orcid.org/0000-0001-5878-108X)
- Rui‐Lan He
- Minxia Wu (ORCID: https://orcid.org/0009-0001-8455-0426)
- Wenjing Yi (ORCID: https://orcid.org/0000-0001-6192-6710)
- Gao Yi-qian
- Junwei Zhang (ORCID: https://orcid.org/0000-0002-3857-3205)
- Huan-Huan Zhang
- Bin Zheng
- Jian-Feng Jiang
- Mo-Jun Lin
- Meng-Ge Yao
Institutions
- Fujian Medical University (CN)
- Union Hospital (CN)
Publication Details
- Journal
- Cell Biology and Toxicology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1007/s10565-026-10349-y
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
- Fujian Medical University